8-KOther EventsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Corporate Update (Jun 28, 2006)

Filed June 28, 2006For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed an 8-K on June 28, 2006, to report an important product safety and recall event. The company announced on June 26, 2006, that it was initiating the retrieval of a specific subset of pacemakers, cardiac resynchronization pacemakers, and implantable cardioverter defibrillators (ICDs) from its sales force and hospital inventories. This action is a proactive measure to address safety concerns related to these devices. While the filing does not detail the exact nature of the safety issue, it signals a significant event for the company, potentially impacting product lines, customer trust, and financial results due to recall costs and potential sales disruptions. Investors should closely monitor subsequent communications from Boston Scientific for further details on the scope, cause, and resolution of this issue.

Key Highlights

  • 1Boston Scientific is recalling a specific subset of pacemakers, cardiac resynchronization pacemakers, and implantable cardioverter defibrillators (ICDs).
  • 2The recall involves retrieving devices from sales force and hospital inventories.
  • 3The announcement was made on June 26, 2006, and reported via an 8-K filing on June 27, 2006.
  • 4This is being treated as an 'Other Event' under Item 8.01 of the 8-K.
  • 5The company provided a press release dated June 26, 2006, as Exhibit 99.1 to the filing, which contains further details on the event.
  • 6The filing does not specify the exact safety concern or the number of devices affected, only a 'specific subset'.

Frequently Asked Questions

Boston Scientific is recalling a specific subset of pacemakers, cardiac resynchronization pacemakers, and implantable cardioverter defibrillators (ICDs).

The 8-K filing states that the company is providing safety information and retrieving these devices, indicating a safety concern. However, the filing does not provide specific details about the nature of the safety issue. More information is likely contained in the referenced press release (Exhibit 99.1).

The filing mentions a 'specific subset' of devices, but does not provide a quantitative number for how many units are being recalled. Investors would need to refer to the accompanying press release for potentially more detailed information.

This recall could lead to immediate costs associated with retrieving the devices, potential financial impact from lost sales, and scrutiny regarding product safety. The long-term impact will depend on the severity of the safety issue, the company's response, and customer confidence.